Add to ORKGThe third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellula
The glycopeptide antimicrobials are a group of natural product and semisynthetic glycosylated peptid...
The spread of resistance among Gram-positive and Gram-negative bacteria represents a growing challen...
The objective of this study was to evaluate the reversal of multidrug resistance of human cell lines...
The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance...
Objectives: The use of efflux pump inhibitors may be a powerful strategy to overcome transporter-med...
Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cas...
P-glycoprotein (P-gp) is a key player in the multidrug-resistant phenotype in cancer. The protein co...
Multidrug resistance (MDR) is a complex phenomenon principally due to the overexpression of some tra...
Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cas...
Background and objective P-glycoprotein (P-gp), a transmembrane transporter expressed at the bloodb...
Doxorubicin is a strong inducer of immunogenic cell death (ICD), but it is ineffective in P-glycopro...
ATP-binding cassette (ABC) transporters, such as P-glycoprotein (P-gp) and breast cancer resistance ...
International audiencePeptidoglycan is the main component of the bacterial cell wall. It is a comple...
Multidrug resistant bacteria are now ubiquitous in both hospital settings and the larger community.1...
The incidence of multidrug-resistant (MDR) organisms, including methicillin-resistant Staphylococcus...
The glycopeptide antimicrobials are a group of natural product and semisynthetic glycosylated peptid...
The spread of resistance among Gram-positive and Gram-negative bacteria represents a growing challen...
The objective of this study was to evaluate the reversal of multidrug resistance of human cell lines...
The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance...
Objectives: The use of efflux pump inhibitors may be a powerful strategy to overcome transporter-med...
Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cas...
P-glycoprotein (P-gp) is a key player in the multidrug-resistant phenotype in cancer. The protein co...
Multidrug resistance (MDR) is a complex phenomenon principally due to the overexpression of some tra...
Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cas...
Background and objective P-glycoprotein (P-gp), a transmembrane transporter expressed at the bloodb...
Doxorubicin is a strong inducer of immunogenic cell death (ICD), but it is ineffective in P-glycopro...
ATP-binding cassette (ABC) transporters, such as P-glycoprotein (P-gp) and breast cancer resistance ...
International audiencePeptidoglycan is the main component of the bacterial cell wall. It is a comple...
Multidrug resistant bacteria are now ubiquitous in both hospital settings and the larger community.1...
The incidence of multidrug-resistant (MDR) organisms, including methicillin-resistant Staphylococcus...
The glycopeptide antimicrobials are a group of natural product and semisynthetic glycosylated peptid...
The spread of resistance among Gram-positive and Gram-negative bacteria represents a growing challen...
The objective of this study was to evaluate the reversal of multidrug resistance of human cell lines...